LAM
CODX

LifePro Asset Management’s Co-Diagnostics CODX Stock Holding History

LifePro Asset Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-638
Closed -$186K – 131
2021
Q3 		$186K Buy
+638
New +$186K 0.06% 96

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LifePro Asset Management's CODX Position: Q4 2021 in Review

LifePro Asset Management sold out of Co-Diagnostics (CODX) in Q4 2021, closing a stake of 638 shares — an estimated $186K sold.

LifePro Asset Management first reported a position in CODX in Q3 2021 and held it in 1 quarter. The position peaked at $186K in Q3 2021. 77 funds tracked by Wall St. Rank hold CODX as of Q4 2021.

  • LifePro Asset Management reported no remaining Co-Diagnostics position as of Q4 2021 after selling out during the quarter.
  • LifePro Asset Management sold 638 Co-Diagnostics shares in Q4 2021, an estimated $186K.
  • LifePro Asset Management first reported a position in Co-Diagnostics in Q3 2021 and held it in 1 quarter.
  • LifePro Asset Management's Co-Diagnostics position peaked at $186K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2021.

Based on LifePro Asset Management's 13F filing for Q4 2021, filed 31 Jan 2022.